{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:03:33Z","timestamp":1648969413666},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143492","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T14:15:37Z","timestamp":1449584137000},"page":"e0143492","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01529073","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Juan","family":"Mac\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Ojeda-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00aaJos\u00e9","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcial","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivas-","family":"Jerem\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"issue":"Suppl 2","key":"ref1","first-page":"61","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"W Sievert","year":"2011"},{"issue":"Suppl 2","key":"ref2","first-page":"30","article-title":"A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel","volume":"31","author":"M Cornberg","year":"2011"},{"key":"ref3","first-page":"710","article-title":"Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4","volume":"15","author":"L Martin-Carbonero","year":"2008"},{"key":"ref4","first-page":"110","article-title":"Prevalence and genotype distribution changes in hepatitis C virus co-infection among human immunodeficiency virus-infected patients","volume":"33","author":"C Cifuentes","year":"2015"},{"key":"ref5","first-page":"233","article-title":"Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy","volume":"20","author":"J Serpaggi","year":"2006"},{"key":"ref6","first-page":"3832","article-title":"Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles","volume":"47","author":"J de Bruijne","year":"2009"},{"key":"ref7","first-page":"167","article-title":"Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4","volume":"10","author":"V Soriano","year":"2005"},{"key":"ref8","first-page":"1721","article-title":"Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients","volume":"26","author":"JA Mira","year":"2012"},{"key":"ref9","first-page":"788","article-title":"Prediction of response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load","volume":"56","author":"K Neukam","year":"2012"},{"key":"ref10","article-title":"Ledipasvir\/sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1: ION-4","author":"S Naggie","year":"2015"},{"key":"ref11","article-title":"Daclatasvir in Combination With Sofosbuvir for HIV\/HCV Coinfection: ALLY-2 Study","author":"D Wyles","year":"2015"},{"key":"ref12","first-page":"56","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"BE Korba","year":"2008"},{"key":"ref13","first-page":"856","article-title":"Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin","volume":"136","author":"JF Rossignol","year":"2009"},{"key":"ref14","first-page":"504","article-title":"Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide","volume":"44","author":"JF Rossignol","year":"2010"},{"key":"ref15","first-page":"59","article-title":"IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4","volume":"20","author":"N Antaki","year":"2013"},{"key":"ref16","first-page":"199","article-title":"Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study","volume":"109","author":"SM Kamal","year":"2014"},{"key":"ref17","first-page":"274","article-title":"Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naive to HCV therapy: results of the ACTG A5269 trial","volume":"14","author":"VK Amorosa","year":"2013"},{"issue":"Suppl 1","key":"ref18","first-page":"24","article-title":"Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues","volume":"34","author":"G Esmat","year":"2014"},{"key":"ref19","first-page":"948","article-title":"Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study","volume":"64","author":"C Hezode","year":"2015"},{"key":"ref20","first-page":"1047","article-title":"Efficacy and safety of simeprevir with PegIFN\/ribavirin in naive or experienced patients infected with chronic HCV genotype 4","volume":"62","author":"C Moreno","year":"2015"},{"key":"ref21","first-page":"1878","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"E Lawitz","year":"2013"},{"key":"ref22","first-page":"2502","article-title":"Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial","volume":"385","author":"C Hezode","year":"2015"},{"key":"ref23","first-page":"1098","article-title":"Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study","volume":"385","author":"JM Molina","year":"2015"},{"key":"ref24","first-page":"94","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"JF Rossignol","year":"2014"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:35:27Z","timestamp":1540024527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143492"}},"subtitle":[],"editor":[{"given":"Chien-Wei","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143492","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}